Insilico Medicine Company

AI-driven drug discovery company founded in 2014 and headquartered in Hong Kong with global R&D centers. Insilico integrates generative AI, target identification, and small-molecule design into an end-to-end platform. The company advances its own pipeline (fibrosis, oncology, immunology) while partnering with major pharma firms. Insilico is recognized for pioneering AI-designed drugs entering clinical trials. (insilico.com)

Invests into

Investors

Connections

Connections from

Headquarters: 1000 Massachusetts Avenue, Suite 126, Cambridge, MA
Founded Date: 2014
Employee Number: 9
Estimated Revenue: No public info
Register and Claim Ownership